1. Home
  2. RNAZ vs UUU Comparison

RNAZ vs UUU Comparison

Compare RNAZ & UUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNAZ
  • UUU
  • Stock Information
  • Founded
  • RNAZ 2016
  • UUU 1969
  • Country
  • RNAZ United States
  • UUU United States
  • Employees
  • RNAZ N/A
  • UUU N/A
  • Industry
  • RNAZ Biotechnology: Pharmaceutical Preparations
  • UUU Electronic Components
  • Sector
  • RNAZ Health Care
  • UUU Technology
  • Exchange
  • RNAZ Nasdaq
  • UUU Nasdaq
  • Market Cap
  • RNAZ 4.9M
  • UUU 5.1M
  • IPO Year
  • RNAZ 2021
  • UUU N/A
  • Fundamental
  • Price
  • RNAZ $3.92
  • UUU $2.31
  • Analyst Decision
  • RNAZ Strong Buy
  • UUU
  • Analyst Count
  • RNAZ 1
  • UUU 0
  • Target Price
  • RNAZ $20.00
  • UUU N/A
  • AVG Volume (30 Days)
  • RNAZ 69.9K
  • UUU 41.2K
  • Earning Date
  • RNAZ 11-14-2024
  • UUU 02-18-2025
  • Dividend Yield
  • RNAZ N/A
  • UUU N/A
  • EPS Growth
  • RNAZ N/A
  • UUU N/A
  • EPS
  • RNAZ N/A
  • UUU N/A
  • Revenue
  • RNAZ N/A
  • UUU $21,288,232.00
  • Revenue This Year
  • RNAZ N/A
  • UUU N/A
  • Revenue Next Year
  • RNAZ $233.33
  • UUU N/A
  • P/E Ratio
  • RNAZ N/A
  • UUU N/A
  • Revenue Growth
  • RNAZ N/A
  • UUU N/A
  • 52 Week Low
  • RNAZ $3.21
  • UUU $1.11
  • 52 Week High
  • RNAZ $264.00
  • UUU $2.47
  • Technical
  • Relative Strength Index (RSI)
  • RNAZ 23.92
  • UUU 62.06
  • Support Level
  • RNAZ $6.63
  • UUU $2.12
  • Resistance Level
  • RNAZ $8.46
  • UUU $2.25
  • Average True Range (ATR)
  • RNAZ 1.05
  • UUU 0.07
  • MACD
  • RNAZ -0.22
  • UUU -0.00
  • Stochastic Oscillator
  • RNAZ 8.04
  • UUU 51.52

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a clinical-stage oncology company focused on treating metastatic disease. It is committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics based on its proprietary TTX nanoparticle platform. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic tumors which overexpress microRNA-10b, a unique, well-documented biomarker of metastasis. In addition, TransCode is developing a portfolio of first-in-class RNA therapeutic candidates designed to overcome the challenges of RNA delivery and thus unlock therapeutic access to a variety of novel genetic targets that could be relevant to treating a variety of cancers.

About UUU Universal Security Instruments Inc.

Universal Security Instruments Inc is a U.S based manufacturer and distributor of safety and security devices in the Peoples Republic of China . The company markets a line of residential smoke and carbon monoxide alarms under the trade names UNIVERSAL and USI Electric. It also markets products to the electrical distribution trade such as electrical and lighting distributors as well as manufactured housing companies. Its product portfolio consists of smoke and fire alarms, carbon monoxide alarms, multi-gas alarms, universal smoke sensing technology, and plug-in alarms.

Share on Social Networks: